20.09.2012 • NewsCytecchemical industrycoating resins

Advent, Rhone Group Lead Bidders for Cytec Unit

Private equity firms Advent International and Rhone Group have emerged as the lead bidders for Cytec Industries's coating resins business that could fetch around $1 billion, according to two people familiar with the matter.

The specialty chemicals company has narrowed the list of potential buyers to Advent and Rhone after reviewing final bids, and is expected to make a decision about a buyer soon, the people said on Wednesday.

The other suitors that also pursued a buyout of the Cytec business, such as Apollo Global Management are no longer involved in the auction, according to the sources and other people familiar with the matter.

Cytec said in May it started looking for a buyer for the business, which makes coating products such as varnishes and specialty paints and represented roughly half of the company's revenues last year.

The sources asked not to be named because details of the auction are not public.

JPMorgan Chase, which is advising Cytec on the sale, declined to comment, so did representatives of Advent and Rhone Group. Cytec and Apollo were not immediately available for comment.

Its coating resins business makes materials used in products ranging from printing inks and papers to cars and cell phones.

The business has been less profitable than Cytec's other segments that make adhesives and other products for aerospace and industrial markets, as well as mining chemicals and additives for plastics.

Cytec has said it will focus on expanding in its higher-margin segments and in April announced a $439 million deal to buy UK-based Umeco, whose products include materials for Formula One cars.

 

 

 

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.